pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

HHS staff push back on new performance review rules amid post-DOGE layoffs

Oct 16, 2026·read at STAT ↗Negative

Federal employees at the Department of Health and Human Services are being asked to submit lengthy self-assessments as part of a revised annual performance review system.

The change follows guidance from the Trump administration to "calibrate" ratings so that high scores are more meaningful and to ensure consistency across agencies.

Workers, still reeling from layoffs during the DOGE era, view the new requirement with suspicion, fearing it could be used to cut pay or force out staff.

The administration says the measure is necessary for credible evaluations, but federal health employees told STAT the policy adds to existing tension and morale concerns.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: In DOGE’s aftermath, federal health workers bristle at new performance reviews”

read at STAT ↗
431 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Peptide Therapeutic

related stories

  • Jul 16Merck wins first approval of a PCSK9 cholesterol pillBioPharma Dive
  • Jul 16Opinion: The growing fang-to-pharmacy pipelineSTAT
  • Jul 14Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillBioPharma Dive
  • Jul 8Opinion: The AI licensure debate is missing the point of licensureSTAT
  • Jul 8Opinion: STAT+: What’s the right role for AI in dementia care?STAT